Global Pharmaceutical Mass Flow Controller Market - 2020-2027

出版日: | 発行: DataM Intelligence | ページ情報: 英文 183 Pages | 納期: 即日から翌営業日

価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.88円
出版日: 2021年03月31日
発行: DataM Intelligence
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
● ご注意事項
  • 全表示
  • 概要
  • 目次




第1章 世界の医薬品向けマスフローコントローラー市場:調査手法と調査範囲

第2章 世界の医薬品向けマスフローコントローラー市場:ヘッドラインと動向

第3章 世界の医薬品向けマスフローコントローラー市場:業界分析

  • 市場促進要因
  • 市場抑制要因
  • ポーターのファイブフォース分析

第4章 世界の医薬品向けマスフローコントローラー市場:セグメンテーション

  • 製品タイプ別
    • サーマルフローメーター
    • 差圧流量計
    • コリオリ質量流量計
  • 流体別
    • 液体
    • ガス
    • 固体
  • 流量別
    • 高流量
    • 低流量
    • 中流量
  • 材料別
    • エキゾチック合金
    • ステンレス鋼
    • その他

第5章 世界の医薬品向けマスフローコントローラー市場の地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
    • 北米
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア
    • その他のアジア太平洋地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • その他の地域

第6章 世界の医薬品向けマスフローコントローラー市場:競合情勢

  • 市場シェア分析
  • 企業ベンチマーキング
  • 主要企業による主要戦略

第7章 企業プロファイル

  • Azbil Corporation
  • Alicat Scientific
  • Brooks Instrument
  • Horiba
  • Bronkhorst
  • Burkert
  • Parker Hannifin
  • MKS Instruments
  • Sierra Instruments
  • Sensirion
  • Vogtlin
  • Tokyo Keiso
  • Teledyne Hastings、など

第8章 世界の医薬品向けマスフローコントローラー市場:付録


Market Overview

The global pharmaceutical mass flow controller market is expected to grow at a CAGR of 6.4% during the forecasting period (2020-2027), owing to growing demand for low flow rate controlling devices for precise measurements. Increasing developments in the laboratory & biomedical research sector that requires gas flow measurement under controlled conditions is expected to drive the mass flow controller market growth over the forecast period.

The global pharmaceutical mass flow controller market is multiplying due to the rising need for reliable and efficient measurement of liquid and gas flow. There are many challenges faced by the pharmaceutical industry during productions of various products. Hence, precise measurements are required to control and accuracy throughout the production processes.

By using mass flow controllers, pharmaceutical companies have improved the accuracy and reliability of air flow measurement; improved performance of the air handling units; and reduced installation and maintenance costs. As medical & Pharmaceutical market is growing due to growing aging population, the mass flow controller for the pharmaceutical industry is expected grow with more opportunities.

Current and Post-COVID-19 growth prospects in pharmaceuticals and healthcare industries are the major factors driving the growth of the pharmaceuticals mass flow controller market. Mass flow controllers play an crucial role in the quality control of different types of medical devices, and several major companies have grabbed the opportunity to fight against the deadly coronavirus pandemic. For instance, RedySmart mass flow controllers of Sierra Instruments provide critical gas flow control systems for bioreactors to scale vaccines from lab to pilot to full-scale production.

Market Dynamics

The mass flow controller (MFC) is commonly used in many bioprocessing systems to manage the flow of different gases into bioreactor chambers. Intelligent MFC technology with digital-based flow-control capabilities can help deliver more precise and versatile gas flow control, more sophisticated analysis, and resolution of process issues, and can also help equip bioprocess scientists and engineers with data that could lead to improved bioreactor performance. It plays an essential role in maintaining a bioreactor's-controlled environment and achieving optimal cell growth.

Two critical factors that govern cell culture yield are the levels of dissolved oxygen (DO) in the bioreactor and the pH of the fermentation broth. For bioprocessing engineers, who focus on optimizing performance, controlling costs, and satisfying strict regulatory requirements MFCs provide a key tool for managing specific bioreactors as well as overall bioprocessing system performance, reducing unscheduled downtime and maximizing integrity tester and bioreactor uptime and yields. The mass flow controller (MFC) has the application of bioreactors, including fermenters, are for production of bioethanol and other biofuels, pharmaceutical products, fine chemical products, food and beverages and tissue growth. As dosing of Air, N2, O2 and CO2 into microbial and cell cultivation is critical.

Market Segmentation analysis

By Product

Based on product type pharmaceutical mass flow controller market is segmented by Thermal Flow Meter, Differential Pressure Flow Meter, Coriolis Mass Flow Meter and others. As the temperature probes need only a very small cross-section, their impact on gas flow is minimal. Thus, one of the biggest advantages of the thermal mass flow meter is that it imposes negligible pressure drop.  As the pharmaceutical industry uses a lot gas, thermal mass flow meters are the preferred over other meters for gas flow measurement. Thermal mass flow meters has several advantages such as:

  • Maximize Product Consistency: In tablet and coating processes, airflow transports the coating to the pills or tablets. Drift or fluctuations in airflow will alter coating thickness and leave it uneven. To avoid this, the flow meter must not only be accurate, but also respond quickly to minimize deviations.
  • Track Gas Usage: Most manufacturers that use gases like nitrogen, carbon dioxide, and oxygen will want to track consumption. Sub-metering allows monitoring down to individual room, line, or even machine level and identifies any abnormal usage trends indicative of leaks or process problems.
  • Reduce Waste: In the pharmaceutical industry, variation leads to waste. By identifying and then reducing variation, engineers can improve yields while curtailing excess consumption.
  • Minimize Measurement Costs: Installing a gas flow measurement device or system will impose certain costs including equipment purchase and installation and meter calibration and maintenance.

Geographical Analysis

The North America is expected to hold the largest share of about XX% in the global pharmaceutical mass flow controller market in 2019, owing to the increasing implementation of these controllers in pharmaceutical industries.

North America pharmaceutical mass flow controller and it is estimated to grow at a CAGR of 6.5% during the forecast period (2020-2027)  As of 2019, there are more than 800 active Investigational New Drug (IND) waiting for approval with the FDA. These burgeoning approvals and drug-developing pipelines are expected to promise more opportunities to market. Apart from this, the US Government has increased the overall healthcare expenditure propelling the market growth. Pharmaceutical manufacturers have increased the investments in R&D for the development of better-quality mass flow controller since it has a direct effect on the safety and efficacy of the drug.

For instance, ventilation devices used during emergency treatment are required for providing an optimum flow of oxygen to the ailing patient. In this case, the performance capability of mass flow controllers is crucial.

The United States healthcare spending is expected to have a 0.8% faster growth than the gross domestic product (GDP) per year over the 2018-27 period. The health share of GDP would rise from 17.9% in 2017 to 19.4% by 2027, as per estimates from the Centers for Medicare & Medicaid Services. The stricter regulation in the country ensures superior quality of the manufacturing and the end-product that is being adhered to by the CMOs.

Competitive Landscape

The pharmaceutical mass flow controller is a fragmented market with the presence of large number of market players. The key players operating in pharmaceuticals mass flow controller market include Azbil Corporation, Brooks Instrument, Bronkhorst, Burkert, Sierra Instrument, Vogtlin, Tokyo Keiso, Teledyne Hastings, Alicat Scientific, and Parker Hannifin.

These companies are launching new innovative solutions with advanced technologies. They are focused on providing efficient products to consumer industries to gain a competitive edge.

The key market players are adopting various strategies such as mergers and acquisitions, product approvals, and agreements to increase product reach and strengthen their product portfolios, in order to enter or expand their business offerings and competitiveness in the pharmaceutical mass flow controller market. For instance, In December 2020, Brooks Instrument, added the GT1600 Series of glass tube variable area flow meters to its industry-leading family of variable area flow meter products. Suitable for a wide variety of industries from chemical manufacturing to pharmaceutical production to water treatment and distribution, the GT1600 is ideal for low- and high-flow gas and liquid applications where viewing the process is important. In October 2019, MKS Instruments launched next-generation C-series mass flow controllers, which uses Micro-Electromechanical Systems (MEMS) technology combined with a fast-acting control valve and MKS proprietary algorithms resulting in an ultra-fast control time of less than 100 milliseconds.

In July 2019, Brooks Instrument (US) launched two new mass flow controllers- the SLA5800 Series Biotech and the SLAMf series Biotech designed for biotechnology applications. In January 2019, Bronkhorst High-Tech (Netherlands) launched the IN-FLOW series of mass flow meters and controllers featuring a rugged, IP65-rated dustproof and waterproof design. Available for flow ranges from 0.05-1 mln/min up to 200-10000 m³n/h air-equivalent, the IN-FLOW series flow meters come with optional ATEX approval for use in Category 3, Zone 2 hazardous areas and are now offered with FM approval for Class I, Division 2 to meet the needs of the North American market.

Why purchase the report?

  • Visualize the composition of the Pharmaceutical Mass Flow Controller market across each indication, regarding type and applications, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in Pharmaceutical Mass Flow Controller by analyzing trends and co-development deals.
  • This is the most comprehensive study on Pharmaceutical Mass Flow Controller to date.
  • Excel data sheet with thousands of data points of the Pharmaceutical Mass Flow Controller market -level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key Pharmaceutical Mass Flow Controller products of all major market players.

Target Audience of this report:

  • Raw Material Suppliers/ Buyers
  • Product Suppliers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Pharmaceutical Mass Flow Controller market - Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Scope of the Report

2. Global Pharmaceutical Mass Flow Controller market -Headlines & Trends

  • 2.1. Headlines
  • 2.2. Key Trends & Developments

3. Global Pharmaceutical Mass Flow Controller market -Industry Analysis

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Porters five forces Analysis
    • 3.3.1. Buyer power
    • 3.3.2. Supplier power
    • 3.3.3. Industry Competition
    • 3.3.4. Threat of new entrant
    • 3.3.5. Threat of Substitutes

4. Global Pharmaceutical Mass Flow Controller market -Segmentation

  • 4.1. By Product Type
    • 4.1.1. Thermal Flow Meter
    • 4.1.2. Differential Pressure Flow Meter
    • 4.1.3. Coriolis Mass Flow Meter
  • 4.2. By Fluid
    • 4.2.1. Liquid
    • 4.2.2. Gas
    • 4.2.3. Solid
  • 4.3. By Flow Rate
    • 4.3.1. High Flow Rate
    • 4.3.2. Low Flow Rate
    • 4.3.3. Medium Flow Rate
  • 4.4. By Material
    • 4.4.1. Exotic Alloys
    • 4.4.2. Stainless Steel
    • 4.4.3. Others

5. Global Pharmaceutical Mass Flow Controller market Geographic Analysis

  • 5.1. North America
    • 5.1.1. The USA
    • 5.1.2. Canada
    • 5.1.3. Mexico
    • 5.1.4. Rest of North America
  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. The UK
    • 5.2.4. Italy
    • 5.2.5. Spain
    • 5.2.6. Rest of Europe
  • 5.3. Asia Pacific
    • 5.3.1. China
    • 5.3.2. Japan
    • 5.3.3. India
    • 5.3.4. Australia
    • 5.3.5. Rest of Asia Pacific
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
    • 5.4.3. Rest of South America
  • 5.5. Rest of World

6. Global Pharmaceutical Mass Flow Controller market - Competitive Landscape

  • 6.1. Market Share Analysis
  • 6.2. Company Benchmarking
  • 6.3. Key Strategies Adopted by Major Companies

7. Company Profiles*

  • 7.1. Azbil Corporation
  • 7.2. Alicat Scientific
  • 7.3. Brooks Instrument
  • 7.4. Horiba
  • 7.5. Bronkhorst
  • 7.6. Burkert
  • 7.7. Parker Hannifin
  • 7.8. MKS Instruments
  • 7.9. Sierra Instruments
  • 7.10. Sensirion
  • 7.11. Vogtlin
  • 7.12. Tokyo Keiso
  • 7.13. Teledyne Hastings

8. Global Pharmaceutical Mass Flow Controller market -Appendix

  • 8.1. Sources
  • 8.2. List of Charts/Tables
  • 8.3. Expert Panel Validation
  • 8.4. Disclaimer
  • 8.5. Contact Us
  • Note: Additional Company Profiles will be included on request